pI: 6.8145 |
Length (AA): 1249 |
MW (Da): 140165 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
153 | 849 | 5jxr (A) | 87 | 709 | 40.00 | 0 | 1 | 0.784346 | 0.41 |
555 | 877 | 5jxt (B) | 407 | 732 | 50.00 | 0 | 1 | 0.811807 | -0.09 |
645 | 758 | 4d25 (A) | 422 | 535 | 25.00 | 0.84 | 0.99 | 0.492473 | -1.08 |
915 | 1155 | 2y9y (A) | 810 | 1056 | 30.00 | 0 | 1 | 0.525154 | 0.22 |
926 | 1158 | 1ofc (X) | 703 | 969 | 38.00 | 0 | 1 | 0.611749 | -0.51 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 merozoite. | Hehl AB |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127117)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G18620 | chromatin remodeling factor17 |
Arabidopsis thaliana | AT3G06400 | chromatin-remodeling protein 11 |
Babesia bovis | BBOV_IV008380 | SNF2 helicase, putative |
Brugia malayi | Bm1_02485 | Potential global transcription activator SNF2L, putative |
Candida albicans | CaO19.7401 | ATPase |
Candida albicans | CaO19.4437 | chromosome structure |
Candida albicans | CaO19.11916 | chromosome structure |
Caenorhabditis elegans | CELE_F37A4.8 | Protein ISW-1 |
Cryptosporidium hominis | Chro.60441 | hypothetical protein |
Cryptosporidium hominis | Chro.80323 | chromatin remodelling complex protein SNF2L |
Cryptosporidium parvum | cgd8_2770 | SNF2L ortholog with a SWI/SNF2 like ATpase and a Myb domain |
Cryptosporidium parvum | cgd6_3860 | SNF2 helicase, putative |
Dictyostelium discoideum | DDB_G0292948 | ATP-dependent chromatin-remodelling factor |
Drosophila melanogaster | Dmel_CG8625 | Imitation SWI |
Echinococcus granulosus | EgrG_001187700 | SWI:SNF matrix associated |
Entamoeba histolytica | EHI_044890 | helicase, putative |
Echinococcus multilocularis | EmuJ_001187700 | SWI:SNF matrix associated |
Giardia lamblia | GL50803_8228 | DNA-dependent ATPase, putative |
Homo sapiens | ENSG00000153147 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
Homo sapiens | ENSG00000102038 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
Leishmania braziliensis | LbrM.33.1970 | transcription activator,DNA-dependent ATPase, putative |
Leishmania donovani | LdBPK_331800.1 | chromatin-remodeling complex atpase chain iswi |
Leishmania infantum | LinJ.33.1800 | transcription activator,DNA-dependent ATPase, putative |
Leishmania major | LmjF.33.1700 | transcription activator,DNA-dependent ATPase, putative |
Leishmania mexicana | LmxM.32.1700 | transcription activator,DNA-dependent ATPase, putative |
Loa Loa (eye worm) | LOAG_06686 | transcription activator |
Mus musculus | ENSMUSG00000031099 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
Mus musculus | 93762 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
Neospora caninum | NCLIV_004490 | hypothetical protein |
Neospora caninum | NCLIV_033850 | hypothetical protein |
Oryza sativa | 4325731 | Os01g0367900 |
Oryza sativa | 4337825 | Os05g0150300 |
Plasmodium berghei | PBANKA_0942700 | chromatin remodeling protein, putative |
Plasmodium falciparum | PF3D7_1104200 | chromatin remodeling protein |
Plasmodium knowlesi | PKNH_0901800 | chromatin remodeling protein, putative |
Plasmodium vivax | PVX_090890 | helicase, putative |
Plasmodium yoelii | PY02376 | SNF2 family N-terminal domain, putative |
Saccharomyces cerevisiae | YBR245C | chromatin-remodeling ATPase ISW1 |
Saccharomyces cerevisiae | YOR304W | Isw2p |
Schistosoma japonicum | Sjp_0053770 | ko:K01529 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 [EC:3.6.1.-], putati |
Schistosoma mansoni | Smp_008830 | helicase |
Schmidtea mediterranea | mk4.001620.04 | Chromatin-remodeling complex ATPase chain isw-1 |
Schmidtea mediterranea | mk4.000783.09 | Chromatin-remodeling complex ATPase chain isw-1 |
Schmidtea mediterranea | mk4.000775.16 | |
Schmidtea mediterranea | mk4.003083.00 | |
Trypanosoma brucei gambiense | Tbg.972.2.360 | transcription activator, putative |
Trypanosoma brucei | Tb927.2.1810 | chromatin-remodeling complex atpase chain iswi |
Trypanosoma congolense | TcIL3000_2_50 | chromatin-remodeling complex atpase chain iswi |
Trypanosoma cruzi | TcCLB.509213.170 | chromatin-remodeling complex atpase chain iswi |
Trypanosoma cruzi | TcCLB.507265.15 | ISWI complex protein |
Toxoplasma gondii | TGME49_273870 | SWI2/SNF2 ISWI-like (AT hook) |
Toxoplasma gondii | TGME49_321440 | SWI2/SNF2 ISWI-like SANT |
Theileria parva | TP01_0936 | DNA-dependent ATPase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.1810 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.1810 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.1810 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.1810 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F37A4.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F37A4.8 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F37A4.8 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_F37A4.8 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F37A4.8 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0942700 | Plasmodium berghei | Essential | plasmo |
TGME49_321440 this record | Toxoplasma gondii | Probably essential | sidik |
TGME49_273870 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.